(5-Aminobenzo[d]isoxazol-3-yl)carbamic acid tert-butyl ester, 95.0%, 1g

tert-Butyl 4-(2-fluoro-4-nitrophenyl)piperazine-1-carboxylate, 95.0%, 10g

(2-Methylpyrimidin-5-yl)methanamine, 95.0%, 100mg

1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide, 98%, 5mg

Fmoc-n-butyl-hydroxylamine, 1g

6-(Cyclopentyloxy)-2-fluoropyridine-3-boronic acid, 97%, 250mg

Z-Asp-(OtBu)-OH, 95%, 10g

Acide urique, min 99 %, pour la biochimie, 250 g, emballage en verre

N-Boc-L-Norvaline ethyl ester, 97.0%, 5g

4-((3S,4R)-3-Methyl-1,6-diazaspiro[3.4]octan-6-yl)-7H-pyrrolo[2,3-d]pyrimidine, 95%, 250mg

4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)aniline, 95.0%, 5g

2-(2-((3-Fluorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

n-(Cyclopropylmethyl)benzo[d][1,3]dioxol-5-amine, 95%, 250mg